1. Home
  2. KREF vs RZLT Comparison

KREF vs RZLT Comparison

Compare KREF & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

HOLD

Current Price

$7.26

Market Cap

416.7M

Sector

Real Estate

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.63

Market Cap

470.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KREF
RZLT
Founded
2014
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.7M
470.9M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
KREF
RZLT
Price
$7.26
$4.63
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$7.88
$9.67
AVG Volume (30 Days)
965.0K
2.3M
Earning Date
04-22-2026
05-13-2026
Dividend Yield
6.49%
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$545.92
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$1.07
52 Week High
$9.98
$11.46

Technical Indicators

Market Signals
Indicator
KREF
RZLT
Relative Strength Index (RSI) 53.33 50.13
Support Level $6.74 $2.91
Resistance Level $7.45 $4.71
Average True Range (ATR) 0.20 0.32
MACD 0.01 -0.10
Stochastic Oscillator 54.27 38.67

Price Performance

Historical Comparison
KREF
RZLT

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: